Skip to main content
. 2021 May 24;7(2):e001615. doi: 10.1136/rmdopen-2021-001615

Figure 2.

Figure 2

Number of patients taking non-steroidal anti-inflammatory drug (NSAID) or analgesics at any point during the trial per treatment group, per visit and type of medication.